These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21767116)
1. Nanoparticles and the skin--applications and limitations. Lane ME J Microencapsul; 2011; 28(8):709-16. PubMed ID: 21767116 [TBL] [Abstract][Full Text] [Related]
2. Combined multiphoton imaging-pixel analysis for semiquantitation of skin penetration of gold nanoparticles. Labouta HI; Kraus T; El-Khordagui LK; Schneider M Int J Pharm; 2011 Jul; 413(1-2):279-82. PubMed ID: 21515347 [TBL] [Abstract][Full Text] [Related]
3. Formation, characterization, and fate of inhaled drug nanoparticles. Zhang J; Wu L; Chan HK; Watanabe W Adv Drug Deliv Rev; 2011 May; 63(6):441-55. PubMed ID: 21118707 [TBL] [Abstract][Full Text] [Related]
4. Skin permeation: the years of enlightenment. Hadgraft J; Lane ME Int J Pharm; 2005 Nov; 305(1-2):2-12. PubMed ID: 16246513 [TBL] [Abstract][Full Text] [Related]
5. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications. Son SJ; Bai X; Lee SB Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547 [TBL] [Abstract][Full Text] [Related]
6. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system. Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450 [TBL] [Abstract][Full Text] [Related]
7. Nanoparticles and microparticles for skin drug delivery. Prow TW; Grice JE; Lin LL; Faye R; Butler M; Becker W; Wurm EM; Yoong C; Robertson TA; Soyer HP; Roberts MS Adv Drug Deliv Rev; 2011 May; 63(6):470-91. PubMed ID: 21315122 [TBL] [Abstract][Full Text] [Related]
8. Unique benefits of nanotechnology to drug delivery and diagnostics. McNeil SE Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949 [TBL] [Abstract][Full Text] [Related]
9. Vesicles as tools for the modulation of skin permeability. Dubey V; Mishra D; Nahar M; Jain NK Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662 [TBL] [Abstract][Full Text] [Related]
11. Advances and challenges of nanotechnology-based drug delivery systems. Jiang W; Kim BY; Rutka JT; Chan WC Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665 [TBL] [Abstract][Full Text] [Related]
12. Breaching the skin's barrier to drugs. Barry BW Nat Biotechnol; 2004 Feb; 22(2):165-7. PubMed ID: 14755286 [No Abstract] [Full Text] [Related]
13. Fabrication of solid nanoparticles for drug delivery. Arayne MS; Sultana N; Noor-Us-Sabah Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113 [TBL] [Abstract][Full Text] [Related]
14. Physical and chemical stability of drug nanoparticles. Wu L; Zhang J; Watanabe W Adv Drug Deliv Rev; 2011 May; 63(6):456-69. PubMed ID: 21315781 [TBL] [Abstract][Full Text] [Related]
15. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Sakagami M Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1030-60. PubMed ID: 17010473 [TBL] [Abstract][Full Text] [Related]
16. Discovery of transdermal penetration enhancers by high-throughput screening. Karande P; Jain A; Mitragotri S Nat Biotechnol; 2004 Feb; 22(2):192-7. PubMed ID: 14704682 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticles made from novel starch derivatives for transdermal drug delivery. Santander-Ortega MJ; Stauner T; Loretz B; Ortega-Vinuesa JL; Bastos-González D; Wenz G; Schaefer UF; Lehr CM J Control Release; 2010 Jan; 141(1):85-92. PubMed ID: 19699771 [TBL] [Abstract][Full Text] [Related]
19. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Godin B; Touitou E Adv Drug Deliv Rev; 2007 Sep; 59(11):1152-61. PubMed ID: 17889400 [TBL] [Abstract][Full Text] [Related]
20. Microneedles for transdermal drug delivery. Prausnitz MR Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]